查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1614263

胞外體研究市場：按產品/服務、適應症、應用和最終用戶 - 2025-2030 年全球預測

Exosome Research Market by Product & Service (Instruments, Kits & Reagents, Services), Indication (Cancer Indication, Cardiovascular Diseases, Infectious Diseases), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年胞外體研究市場價值為2.3098億美元，預計到2024年將達到2.574億美元，複合年成長率為11.85%，到2030年將達到5.0598億美元。

胞外體是細胞外囊泡，在細胞間的通訊中發揮重要作用，在藥物傳遞、診斷和再生醫學等各種科學和醫學領域受到關注。特別是，它在藥物傳輸、診斷和再生醫學等各個科學和醫學領域引起了人們的關注。它們的範圍可實現治療應用，作為生物活性分子的天然載體，並在標靶藥物傳輸和診斷中用作疾病生物標記。胞外體研究的需求源於其透過提供有效治療癌症和神經系統疾病等複雜疾病的尖端解決方案而徹底改變精準醫學的潛力。關鍵的最終用途領域包括製藥、生物技術和臨床環境，我們利用我們的能力來改善患者的治療結果。對非侵入性診斷的需求不斷成長以及對個人化醫療的興趣對市場產生了重大影響。分離和表徵技術的技術進步擴大了研究可能性並推動了該領域的成長。加強胞外體精製方法並擴大其在化妝品和抗衰老產品中的用途存在機會。學術機構和生技公司之間的合作可以進一步加速創新。然而，高研究成本和監管障礙等挑戰可能會阻礙市場成長。此外，胞外體分離和分析的標準化具有複雜的限制。對於公司而言，開發具有成本效益的分離技術以及提高胞外體產量和純度的創新將是一個利潤豐厚的領域。此外，探索胞外體的膜工程和貨物裝載可能會開闢新的治療途徑。市場充滿活力，研發投資的增加和策略聯盟的推動推動了進步。繼續研究胞外體的生物學作用和功能對於解決現有的限制至關重要。最終，促進研究人員和行業相關人員之間的合作將有助於克服挑戰，最大限度地發揮胞外體技術在不同應用中的潛力，並確保永續的市場擴張和技術進步極為重要。

主要市場統計
基準年[2023] 23098萬美元
預計年份 [2024] 2.574 億美元
預測年份 [2030] 50598萬美元
複合年成長率（%） 11.85%

市場動態：揭示快速發展的胞外體研究市場的關鍵市場洞察

胞外體研究市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病和遺傳性疾病盛行率上升
    • 藥物發現和開發活動的擴展以及對有效藥物和基因發行策略的需求
    • 推動基因組和胞外體研究的政府津貼和舉措
  • 市場限制因素
    • 需要複雜先進的設備而缺乏熟練的人才
  • 市場機會
    • 透過整合尖端技術簡化和加速胞外體研究
    • 患者對個人化醫療策略的偏好
  • 市場問題
    • 胞外體研究的技術限制與困難

波特五力：開拓胞外體研究市場的策略工具

波特的五力架構是了解胞外體研究市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解胞外體研究市場的外部影響

外部宏觀環境因素在塑造胞外體研究市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解胞外體研究市場的競爭格局

胞外體研究市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：胞外體研究市場供應商的績效評估

FPNV定位矩陣是評估胞外體研究市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製胞外體研究市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，胞外體研究市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病和遺傳性疾病盛行率上升
      • 擴大藥物發現和開發活動以及對有效藥物和基因遞送策略的需求
      • 推動基因組和胞外體研究的政府津貼和舉措
    • 抑制因素
      • 需要複雜先進的設備而缺乏熟練的人才
    • 機會
      • 融合先進技術，實現效率與速度
      • 患者對個人化醫療策略的偏好
    • 任務
      • 胞外體研究的技術限制與困難
  • 市場區隔分析
    • 產品/服務：用於診斷和治療的胞外體研究服務變得越來越重要
    • 適應症：癌症檢測胞外體研究的進展
    • 應用：胞外體研究在疫苗開發的廣泛應用
    • 最終用戶：將胞外體研究用於醫院和臨床環境中的診斷目的
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章胞外體研究市場：依產品及服務分類

  • 介紹
  • 裝置
  • 試劑套件和試劑
  • 服務

第7章胞外體研究市場：依適應症分類

  • 介紹
  • 癌症適應症
    • 乳癌
    • 大腸直腸癌
    • 肺癌
    • 攝護腺癌
  • 心血管疾病
  • 感染疾病
  • 神經退化性疾病

第8章胞外體研究市場：依應用分類

  • 介紹
  • 生物標記
  • 組織再生
  • 疫苗開發

第 9 章胞外體研究市場：依最終使用者分類

  • 介紹
  • 學術研究所
  • 醫院和臨床實驗室
  • 製藥和生物技術公司

第10章 美洲胞外體研究市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太胞外體研究市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的胞外體研究市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Coya Therapeutics 和休士頓衛理公會研究所開創了對抗神經退化性疾病的胞外體研究
    • Promega 和 INOVIQ Ltd. 合作，利用先進的胞外體工具和人工智慧行銷來改變癌症生物標記研究
    • Creative Proteomics推出先進的胞外體分離與精製服務
    • 總部位於南卡羅來納州的 IMCS 與 Tymora Analytical 合作簡化胞外體研究
    • AGC Biologics 與慈惠醫科大學簽署特發性肺纖維化 (IPF)計劃胞外體協議
  • 戰略分析和建議

公司名單

  • Abcam PLC by Danaher Corporation
  • Alpha Laboratories by Pace Analytical Services
  • AMS BIoTechnology（Europe）Limited
  • AMSBIO
  • BioCat GmbH by AddLife
  • Creative Biolabs
  • Cusabio Technology LLC
  • Fujifilm Holdings Corporation
  • HiSS Diagnostics GmbH
  • Lonza Group Ltd.
  • Malvern Panalytical Ltd.
  • MBL International Corporation
  • Miltenyi BIoTec BV & Co. KG
  • NanoSomiX, Inc.
  • Norgen BIoTek Corp.
  • Nx Pharmagen Inc.
  • QIAGEN NV
  • System Biosciences, LLC
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-AD36CD897B3A

The Exosome Research Market was valued at USD 230.98 million in 2023, expected to reach USD 257.40 million in 2024, and is projected to grow at a CAGR of 11.85%, to USD 505.98 million by 2030.

Exosomes are extracellular vesicles playing key roles in cell communication and are gaining prominence in various scientific and medical fields, notably in drug delivery, diagnostics, and regenerative medicine. Their scope involves acting as natural carriers of bioactive molecules, enabling applications in therapeutics, where they are harnessed for targeted drug delivery and disease biomarkers in diagnostics. The necessity of exosome research stems from its potential to revolutionize precision medicine, offering cutting-edge solutions to effectively treat complex diseases like cancer and neurological disorders. Key end-use sectors include pharmaceuticals, biotechnology, and clinical settings that leverage their capabilities to enhance patient care outcomes. The market is significantly influenced by the rising need for non-invasive diagnostics and interest in personalized medicine. Technological advancements in isolation and characterization techniques amplify research possibilities, facilitating growth in this field. Opportunities lie in enhancing exosome purification methods and expanding their use in cosmeceuticals and anti-aging products. Collaborations between academic institutions and biotech firms could further accelerate innovation. However, challenges like the high cost of research and regulatory hurdles can impede market growth. Additionally, complexities in standardizing exosome isolation and analysis present limitations. For businesses, innovation in the development of cost-effective isolation techniques and enhancing the yield and purity of exosomes represent lucrative areas. Furthermore, exploring exosome membrane engineering and cargo loading could open new therapeutic avenues. The market is dynamic, with increasing R&D investments and strategic partnerships catalyzing progress. Continued research into the biological roles and functions of exosomes is essential to address existing limitations. Ultimately, fostering collaboration between researchers and industry players will be crucial in navigating challenges and unlocking the full potential of exosome technologies in diverse applications, ensuring sustainable market expansion and technological advancement.

KEY MARKET STATISTICS
Base Year [2023] USD 230.98 million
Estimated Year [2024] USD 257.40 million
Forecast Year [2030] USD 505.98 million
CAGR (%) 11.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Exosome Research Market

The Exosome Research Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic disease conditions and genetic disorders
    • Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
    • Government grants and initiatives to advance genome and exosome research
  • Market Restraints
    • Need for complex and sophisticated equipment and lack of skilled personnel
  • Market Opportunities
    • Integration of advanced technologies to streamline and accelerate exosome research
    • Patient preference for personalized medicine strategies
  • Market Challenges
    • Technical limitations and difficulties of exosome research

Porter's Five Forces: A Strategic Tool for Navigating the Exosome Research Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Exosome Research Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Exosome Research Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Exosome Research Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Exosome Research Market

A detailed market share analysis in the Exosome Research Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Exosome Research Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Exosome Research Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Exosome Research Market

A strategic analysis of the Exosome Research Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Exosome Research Market, highlighting leading vendors and their innovative profiles. These include Abcam PLC by Danaher Corporation, Alpha Laboratories by Pace Analytical Services, AMS Biotechnology (Europe) Limited, AMSBIO, BioCat GmbH by AddLife, Creative Biolabs, Cusabio Technology LLC, Fujifilm Holdings Corporation, HiSS Diagnostics GmbH, Lonza Group Ltd., Malvern Panalytical Ltd., MBL International Corporation, Miltenyi Biotec B.V. & Co. KG, NanoSomiX, Inc., Norgen Biotek Corp., Nx Pharmagen Inc., QIAGEN N.V., System Biosciences, LLC, Takara Bio Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Exosome Research Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product & Service, market is studied across Instruments, Kits & Reagents, and Services.
  • Based on Indication, market is studied across Cancer Indication, Cardiovascular Diseases, Infectious Diseases, and Neurodegenerative Diseases. The Cancer Indication is further studied across Breast Cancer, Colorectal Cancer, Lung Cancer, and Prostate Cancer.
  • Based on Application, market is studied across Biomarkers, Tissue Regeneration, and Vaccine Development.
  • Based on End User, market is studied across Academic & Research Institutes, Hospitals & Clinical Testing Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disease conditions and genetic disorders
      • 5.1.1.2. Expanding drug discovery and development activities and the need for efficient drug and gene delivery strategies
      • 5.1.1.3. Government grants and initiatives to advance genome and exosome research
    • 5.1.2. Restraints
      • 5.1.2.1. Need for complex and sophisticated equipment and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced technologies to streamline and accelerate exosome research
      • 5.1.3.2. Patient preference for personalized medicine strategies
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and difficulties of exosome research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product & Service: Rising emphasis on exosome research services for diagnostics and therapeutics applications
    • 5.2.2. Indication: Advancements in exosome research for cancer detection
    • 5.2.3. Application: Broad applications of exosome research for vaccine development
    • 5.2.4. End User: Utilization of exosome research in hospitals and clinical settings for diagnostic purposes
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Exosome Research Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Reagents
  • 6.4. Services

7. Exosome Research Market, by Indication

  • 7.1. Introduction
  • 7.2. Cancer Indication
    • 7.2.1. Breast Cancer
    • 7.2.2. Colorectal Cancer
    • 7.2.3. Lung Cancer
    • 7.2.4. Prostate Cancer
  • 7.3. Cardiovascular Diseases
  • 7.4. Infectious Diseases
  • 7.5. Neurodegenerative Diseases

8. Exosome Research Market, by Application

  • 8.1. Introduction
  • 8.2. Biomarkers
  • 8.3. Tissue Regeneration
  • 8.4. Vaccine Development

9. Exosome Research Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Testing Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Exosome Research Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Exosome Research Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Exosome Research Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Coya Therapeutics and Houston Methodist Research Institute Pioneer Exosome Research to Battle Neurodegenerative Diseases
    • 13.3.2. Promega and INOVIQ Ltd. Team Up to Transform Cancer Biomarker Research with Advanced Exosome Tools and AI Marketing
    • 13.3.3. Creative Proteomics Launches Advanced Exosome Isolation and Purification Service
    • 13.3.4. South Carolina-Based IMCS, Tymora Analytical Partner To Streamline Exosome Research
    • 13.3.5. AGC Biologics Signs Exosome Agreement with The Jikei University in Japan for Idiopathic Pulmonary Fibrosis (IPF) Project
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam PLC by Danaher Corporation
  • 2. Alpha Laboratories by Pace Analytical Services
  • 3. AMS Biotechnology (Europe) Limited
  • 4. AMSBIO
  • 5. BioCat GmbH by AddLife
  • 6. Creative Biolabs
  • 7. Cusabio Technology LLC
  • 8. Fujifilm Holdings Corporation
  • 9. HiSS Diagnostics GmbH
  • 10. Lonza Group Ltd.
  • 11. Malvern Panalytical Ltd.
  • 12. MBL International Corporation
  • 13. Miltenyi Biotec B.V. & Co. KG
  • 14. NanoSomiX, Inc.
  • 15. Norgen Biotek Corp.
  • 16. Nx Pharmagen Inc.
  • 17. QIAGEN N.V.
  • 18. System Biosciences, LLC
  • 19. Takara Bio Inc.
  • 20. Thermo Fisher Scientific Inc.
  • 21. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. EXOSOME RESEARCH MARKET RESEARCH PROCESS
  • FIGURE 2. EXOSOME RESEARCH MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. EXOSOME RESEARCH MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL EXOSOME RESEARCH MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. EXOSOME RESEARCH MARKET DYNAMICS
  • TABLE 7. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY TISSUE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL EXOSOME RESEARCH MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES EXOSOME RESEARCH MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA EXOSOME RESEARCH MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY CANCER INDICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM EXOSOME RESEARCH MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. EXOSOME RESEARCH MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. EXOSOME RESEARCH MARKET, FPNV POSITIONING MATRIX, 2023